Back
InMed Pharmaceuticals Quote, Financials, Valuation and Earnings
The little-known AI stock you need to read about now...
Get the name - FREE.
Sell
36
INM
InMed Pharmaceuticals
Last Price:
0.27
Seasonality Move:
-22.11%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.InMed Pharmaceuticals Price Quote
$0.27
-0.01 (2.58%)
(Updated: May 14, 2024 at 6:14 AM ET)
InMed Pharmaceuticals Key Stats
Sell
36
InMed Pharmaceuticals (INM)
is a Sell
Day range:
$0.25 - $0.29
52-week range:
$0.23 - $2.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.23
P/B ratio:
0.13%
Volume:
168.6K
Avg. volume:
591.8K
1-year change:
-75.66%
Market cap:
$1.7M
Revenue:
$4.1M
EPS:
$-1.27
How Much Does InMed Pharmaceuticals Make?
-
How Much Are InMed Pharmaceuticals's Sales Annually?
INM Revenues are $4.1M -
How Much Profit Does InMed Pharmaceuticals's Make A Year?
INM net income is -$7.9M
Is InMed Pharmaceuticals Growing As A Company?
-
What Is InMed Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.64% -
What Is InMed Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
InMed Pharmaceuticals Stock Price Performance
-
Did InMed Pharmaceuticals Stock Go Up Last Month?
InMed Pharmaceuticals share price went down by -15.05% last month -
Did INM's Share Price Rise Over The Last Year?
INM share price fell by -75.66% over the past 1 year
What Is InMed Pharmaceuticals 52-Week High & Low?
-
What Is InMed Pharmaceuticals’s 52-Week High Share Price?
InMed Pharmaceuticals has traded as high as $2.08 over the past 52 weeks -
What Is InMed Pharmaceuticals’s 52-Week Low Share Price?
InMed Pharmaceuticals has traded as low as $0.23 over the past 52 weeks
InMed Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy InMed Pharmaceuticals?
-
How Much Debt Does InMed Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does InMed Pharmaceuticals Have?
Cash and short term investments quarterly total is $9.5M -
What Is InMed Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.25
Is InMed Pharmaceuticals Cash Flow Positive?
-
What Is INM Cash Flow From Operations?
Cash flow from operations (TTM) is -$6.3M -
What Is InMed Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.6M -
What Is InMed Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$171.1K
InMed Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
INM return on invested capital is -51.92% -
What Is InMed Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -44.15% -
What Is INM Return On Equity?
ROE is a measure of profitability and is -51.92%
InMed Pharmaceuticals Earnings Date & Stock Price
-
What Is InMed Pharmaceuticals's Stock Price Today?
A single share of INM can be purchased today for 0.28 -
What Is InMed Pharmaceuticals’s Stock Symbol?
InMed Pharmaceuticals trades on the nasdaq under the ticker symbol: INM -
When Is InMed Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for InMed Pharmaceuticals is scheduled on May 15, 2024 -
When Is INM's next ex-dividend date?
InMed Pharmaceuticals's next ex-dividend date is May 14, 2024 -
How To Buy InMed Pharmaceuticals Stock?
You can buy InMed Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
InMed Pharmaceuticals Competitors
-
Who Are InMed Pharmaceuticals's Competitors?
Below is a list of companies who compete with InMed Pharmaceuticals or are related in some way:
InMed Pharmaceuticals Dividend Yield
Data Unavailable
InMed Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 163.99% | 11.1% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 20.47 |
| Upside from Last Price: | 7213.69% |